Press

July, 2020 , Mantell Associates Network

Mantell Associates Network

Our CEO, Dr Ross Burn spoke to the Mantell Associates Network podcast about innovation during the COVID-19 pandemic.

By: Ross Burn

July, 2020 , Chemistry Today

Panel Discussion on Catalysis

Our Associate Principal Scientist, Dr Vargini Thangavadivale participated in the latest Chemistry Today panel discussion on catalysis

By: Vargini Thangavadivale

June, 2020 , The Medicine Maker

Pandemic Diaries

Our Chief Operating Officer, Dr Simon Tyler, recently spoke with The Medicine Maker to discuss the continuing impacts of COVID-19 on the pharmaceutical industry

By: Simon Tyler

June, 2020 , Chemicals Knowledge Hub

Chemicals Knowledge Hub

Our CEO, Dr Ross Burn talked to Chemicals Knowledge Hub TV about the origins of CatSci, our strategic shift and exponential growth over the past few years.

By: Ross Burn

April, 2020 , CHEManager International

How a CRO Can effectively Work with Global Clients

Our Head of Business Development for North America, Dr Jas Douville, recently spoke to CHEManager International about how a CRO can succeed in the global marketplace.

By: Jas Douville

April, 2020 , Chemicals Knowledge Hub

Effectively crafting your process development

What is needed to drive effective process development? Understanding how to take a holistic approach to the technical, economic and regulatory factors underpinning your chemistry is crucial. Dr Alan Steven, Senior Principal Scientist at CatSci, explores.

By: Alan Steven

February, 2020 , Careers in Discovery

Careers in Discovery

Our CEO, Dr Ross Burn spoke to the Careers in Discovery podcast about entrepreneurship, his career and CatSci's journey.

By: Ross Burn

January, 2020 , Chemicals Knowledge Hub

Women in science – how ‘fortunate’ do you feel?

Our Business Development Manager, Dr Jenny Wallis recently spoke to Chemicals Knowledge Hub about what it means to be a woman working in the pharmaceutical industry in the 21st century.

By: Jenny Wallis

October, 2019 , The Medicine Maker

Process Development 101: How Not to Burn Down Your Factory

Our Technical Director, Dr Jonathan Moseley, offers tips on how to manufacture your API in the right quantity, at the right cost, and in the right time frame - and not burn your factory down in the process!

By: Jonathan Moseley

September, 2019 , Chemistry Today

Panel Discussion on Custom Synthesis & Contract Manufacturing

Our Chief Operating Officer, Dr Simon Tyler participated in the latest Chemistry Today panel discussion on custom synthesis and manufacturing.

By: Simon Tyler

September, 2019 , CHEManager International

The pharma CDMO challenge

Our Business Development Manager, Dr Joao Madeira do O recently spoke to CHEManager International to discuss the current market for process research and development CROs like CatSci.

By: Joao Madeira do O

September, 2019 , Chemicals Knowledge Hub

The growth of green chemistry

Our Senior Scientist, Dr Joe Renny recently spoke to Chemicals Knowledge Hub to discuss the importance of exploiting green chemistry to produce perfect for purpose process chemistry solutions.

By: Joseph Renny

May, 2019 , C&EN

British contract research firms fight to find science talent

In C&EN, our COO Dr Simon Tyler discusses the importance of welcoming graduate chemists into our company and how we are dedicated to growing our team with bright, talented minds.

By: Simon Tyler

February, 2019 , The Medicine Maker

Phasing Out Inefficiency

How can you ensure success when working with a CRO, such as CatSci, for process research and development? Hear from our COO, Dr Simon Tyler, in The Medicine Maker.

By: Simon Tyler

January, 2019 , Pharmaceutical Technology

Updating Manufacturing Processes to Improve Sustainability

Earlier this year, CatSci’s Dr. Jonathan Moseley spoke with Pharmaceutical Technology to discuss what makes our novel biocatalytic manufacturing process unique.

By: Jonathan Moseley

October, 2018 , CHEManager

How CDMOs tackle the current market developments

CatSci’s Dr Ross Burn joins several other top industry experts to offer insight into what current market developments are most challenging for Pharma CDMOs and how they can tackle them.

By: Ross Burn

September, 2018 , Chemical Week

Fine chemicals: Pharmaceutical industry outlook is optimistic

Our CEO Dr Ross Burn talks to Michael Ravenscroft about the current trends in CRO outsourcing for the pharmaceutical market.

By: Ross Burn

August, 2018 , Chemistry Today

Outsourcing: optimising an asset and an organisation

In 2018, our CEO Dr Ross Burn took part in Chemistry Today’s Panel Discussion on Custom Synthesis and Contract Manufacturing.

By: Ross Burn

August, 2018 , C&EN

How former drug company labs are becoming contract research firms

Learn about our growth as a contract research organisation for the Pharma industry in this article, featuring our COO, Dr Simon Tyler.

By: Simon Tyler

July, 2018 , Chemicals Knowledge Hub

Optimizing Your Asset, Minimizing the Risk

Dr Ross Burn, CEO and Dr Simon Tyler, COO at CatSci explain how process optimization can play an integral part in optimizing yield while reducing time and costs.

By: Ross Burn

March, 2018 , Chemistry World

Biosensors, wearables and virtual tech

In a world that is racing ahead with new technologies, has the drug development process distanced itself from the patients it ultimately provides for? Hear more from our Chief Executive Officer, Dr. Ross Burn.

By: Ross Burn